Home » Stocks » EMIS

Emisphere Technologies, Inc. (EMIS)

Dec 8, 2020 - EMIS was delisted after being acquired by NVO
Stock Price: $7.81 USD -1,006.19 (-99.23%)
Updated Dec 9, 2021 9:30 AM EST
Market Cap 497.77M
Revenue (ttm) 1.04M
Net Income (ttm) -2.15M
Shares Out 60.71M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day Dec 9, 2021
Last Price $7.81
Previous Close $1,014.00
Change ($) -1,006.19
Change (%) -99.23%
Day's Open 7.81
Day's Range 7.81 - 7.81
Day's Volume 0
52-Week Range 4.06 - 1046


There are no news available yet.

About EMIS

Emisphere Technologies operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and ... [Read more...]

Drug Manufacturers-Specialty & Generic
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2016, EMIS's revenue was $1.20 million, an increase of 190.75% compared to the previous year's $411,000. Losses were -$10.04 million, -75.13% less than in 2015.

Financial Statements